We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Nature | Mar 10, 2011

B-cell non-Hodgkin's lymphoma comprises biologically and clinically distinct diseases the pathogenesis of which is associated with genetic lesions affecting oncogenes and tumour-suppressor genes. We report here that the two most common types--follicular lymphoma and diffuse large B-cell lymphoma--harbour frequent structural alterations inactivating CREBBP and, more rarely, EP300, two highly related histone and non-histone acetyltransferases (HATs) that act as transcriptional co-activators in multiple signalling pathways. Overall, about 39% of diffuse large B-cell lymphoma and 41% of follicular lymphoma cases display genomic deletions and/or somatic mutations that remove or inactivate the HAT coding domain of these two genes. These lesions usually affect one allele, suggesting that reduction in HAT dosage is important for lymphomagenesis. We demonstrate specific defects in acetylation-mediated inactivation of the BCL6 oncoprotein and activation of the p53 tumour suppressor. These results identify CREBBP/EP300 mutations as a major pathogenetic mechanism shared by common forms of B-cell non-Hodgkin's lymphoma, with direct implications for the use of drugs targeting acetylation/deacetylation mechanisms.

Pubmed ID: 21390126 RIS Download

Mesh terms: Acetyl Coenzyme A | Acetylation | Acetyltransferases | Animals | Base Sequence | CREB-Binding Protein | Cells, Cultured | DNA-Binding Proteins | E1A-Associated p300 Protein | Gene Expression Regulation, Neoplastic | HEK293 Cells | Histone Acetyltransferases | Humans | Lymphoma, B-Cell | Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Mice | Mutation | Mutation, Missense | Polymorphism, Single Nucleotide | Protein Binding | Protein Structure, Tertiary | Proto-Oncogene Proteins c-bcl-6 | Recurrence | Sequence Deletion | Tumor Suppressor Protein p53

Research resources used in this publication

None found

Research tools detected in this publication

Data used in this publication

Associated grants

  • Agency: NIAID NIH HHS, Id: U54-AI057158
  • Agency: NCI NIH HHS, Id: R01-CA37295
  • Agency: NIDCR NIH HHS, Id: DE018183
  • Agency: NCI NIH HHS, Id: R37 CA037295-28
  • Agency: NCI NIH HHS, Id: R01 CA037295
  • Agency: NCI NIH HHS, Id: R37 CA037295
  • Agency: NCI NIH HHS, Id: P01 CA092625
  • Agency: NIDCR NIH HHS, Id: R21 DE018183
  • Agency: NCI NIH HHS, Id: P30 CA021765
  • Agency: NIAID NIH HHS, Id: U54 AI057158
  • Agency: NCI NIH HHS, Id: P01-CA092625
  • Agency: NLM NIH HHS, Id: 1R01LM010140-01
  • Agency: NLM NIH HHS, Id: R01 LM010140
  • Agency: NCI NIH HHS, Id: P01 CA092625-05

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Tool used to design PCR primers from DNA sequence - often in high-throughput genomics applications. It does everything from mispriming libraries to sequence quality data to the generation of internal oligos.


View all literature mentions